S4880C

The New York State Senate passed legislation establishing a drug checking services program designed to combat the opioid epidemic by allowing individuals to test substances for dangerous adulterants including fentanyl, xylazine, and newly detected medetomidine. The bill, S4880C, sponsored by Sen. Fernandez, passed 43-18 on a roll call vote. The program would operate in collaboration with the Department of Health and Office of Addiction Services, providing confidential testing without criminal justice involvement. Supporters cited data from San Francisco showing that 30.1% of users whose drugs tested positive for fentanyl reduced their use, and 26.5% disposed of the substances. Opponents, led by Sen. Murray, argued the bill duplicates existing state testing strip distribution programs—which distributed over 9 million fentanyl strips and 6.8 million xylazine strips in 2022—and questioned whether it actually prevents drug use since tested drugs would not be confiscated. Murray contended resources should instead focus on treatment and enforcement against dealers. The bill takes effect 90 days after becoming law.